PR Newswire BiotechnologyQwen · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 20:42:00·⟳ 抓取 20:42:32 +32s·⚡ 决策 08-24 20:48:53 +6m21s·64.2 天前
Abbott Neuromodulation 将南达科他州医生 James Brunz 评为脊髓电刺激(SCS)卓越中心医师——私立诊所自发医生荣誉营销通稿，无可交易增量
这是由未上市私立医生集团自费发布的医生荣誉营销通稿，授予方 Abbott 为超大市值器械公司；事件未披露任何订单、金额、指引或商业化增量。已完成跨源已处理检查（72 小时无同一催化）、直接载体扫描（唯一直接载体为 ABT.US 主上市）、自家案例库复盘（ABT 软消息历来不做）与先例环节（该类事件无市场反应样本，event_study n=0），所有研究均不产生可交易增量，故不做。
📄 原文PR Newswire Biotechnology↗ 原文
James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician TEA…
不做 Abbott Laboratories（ABT.US）
超大市值主标的的软催化：批量医生认证营销通稿，无订单金额、无收入/指引增量，相对超大市值无任何可交易增量；直接受益的医生与私立医生集团均未上市不可交易，二阶传播不改变任何标的/方向/执行，故不做
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
事实：Abbott Neuromodulation 授予南达科他州 Orthopedic Institute 的 James Brunz 医生 SCS 卓越中心医师称号，通稿由该私立机构自行经 PR Newswire 发布，全文无金额、订单或指引。影响链：此类认证是 Abbott 对大量植入医生的批量营销动作，不改变 Abbott 收入/利润/指引，相对其超大市值增量为零；被认证的医生与医生集团均未上市，无证券可交易；也不存在可传导的供应商/客户/竞争链条。证据：正文即完整一手材料；72 小时跨源检查无重复；自家案例库显示 ABT 同类软消息一律判不做；先例库无可测样本。结论：无方向、无增量、无可交易标的，不做。
🔎 新鲜度:最早出现 2026-08-24 · 扩散 low · price-in 风险 low ↗
消息传播链
- 通稿由被认证医生所在的私立机构 Orthopedic Institute 自行发布（SOURCE 落款为该机构），属机构自我宣传而非 Abbott 公司级公告；本条即首发，无更早传播节点市场反应:无：未涉及任何可交易证券的实际定价
先例如何影响了这次决策
对本次决策的影响:先例研究未改变结论：本事件因无增量事实而不做；已实际调用 event_study（空面板，n=0）确认不存在同类可定价样本
方向:无可用方向参考
涨幅量级:无：该类事件不存在可测量的标的级价格反应对象
形态:无
工具调用 · 历史记录,结果未知(6 种)
- fetch_decision_experience · 结果未知
- search_processed_events · 结果未知
- direct_instrument_candidates · 结果未知
- search_case_library · 结果未知
- web_search · 结果未知
- event_study · 结果未知
原文全文
展开原文 · 4,156 字
James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician
TEA, S.D., Aug. 24, 2026 /PRNewswire/ -- James T. Brunz, MD, an interventional spine and pain physician with Orthopedic Institute (OI), has been recognized by Abbott Neuromodulation as a Spinal Cord Stimulation (SCS) Center of Excellence physician based on his experience, clinical insights, and long-standing work with stimulation-based therapies for chronic pain.
According to Abbott Neuromodulation, Dr. Brunz is a strong proponent of spinal cord stimulation therapy and has served as a consultant on product design. He has performed more than 2,000 SCS implants throughout his career. Abbott has indicated that his experience places him among the top 5% of SCS implanters in the Upper Midwest and top 10% across the broader Midwest.
Spinal cord stimulation is an advanced neuromodulation therapy for select patients with chronic pain who have not achieved adequate relief through more conservative treatments. Dr. Brunz's neuromodulation practice includes spinal cord stimulation and dorsal root ganglion (DRG) stimulation, with an emphasis on careful patient selection and appropriate therapy matching.
"Dr. Brunz has demonstrated significant experience and clinical insight in spinal cord stimulation and neuromodulation therapy," said Todd Woodson, Area Vice President, Abbott Neuromodulation. "Based on his experience, procedural history, and contributions as a clinical resource, Abbott Neuromodulation recognizes Dr. Brunz as a Spinal Cord Stimulation Center of Excellence physician."
"I have worked directly with Dr. Brunz in the operating room and have seen firsthand his experience, consistency, and understanding of spinal cord stimulation therapy," said Scott Mattecheck, Territory Manager, Abbott Neuromodulation. "He has been a valuable clinical resource in the region for patients with complex chronic pain."
"Spinal cord stimulation is not appropriate for every patient, but for carefully selected individuals with chronic pain that has not responded to other treatments, it can be an important therapy to consider," said Dr. Brunz. "My focus is identifying the source of a patient's pain and matching the right treatment to the right patient."
A fellowship-trained interventional spine physician with more than 20 years of experience, Dr. Brunz treats complex spine and pain conditions at Orthopedic Institute, collaborating with orthopedic surgeons, rehabilitation specialists, and advanced practice providers.
In addition to his Abbott designation, Dr. Brunz is a listed Intracept Center of Excellence physician for vertebrogenic low back pain. He is the only physician in South Dakota recognized with both the Abbott Neuromodulation Spinal Cord Stimulation Center of Excellence and Intracept Center of Excellence distinctions.
Patients considered for SCS may include those with chronic pain that has not improved adequately with conservative care or previous treatment. Candidates typically complete a temporary stimulation trial before permanent implantation to determine whether the therapy provides meaningful relief.
About Dr. James T. Brunz
James T. Brunz, MD, is a fellowship-trained interventional spine and pain physician at Orthopedic Institute specializing in complex spine and pain conditions. His clinical focus includes vertebrogenic low back pain, basivertebral nerve ablation, spinal cord stimulation, dorsal root ganglion stimulation, and advanced interventional pain care. He has served as a regional clinical resource and key opinion leader in neuromodulation since being recognized by St. Jude Medical/Abbott in 2013.
About Orthopedic Institute
Founded in 1972, Orthopedic Institute (OI) is an independent physician group specializing in orthopedics, sports medicine, and interventional spine and pain care. With 21 physicians and more than 225 employees, OI serves patients across South Dakota, Minnesota, and Iowa from its main clinic in Tea, South Dakota, and regional locations. www.orthopedicinstitutesf.com
Media Contact:
Helen Kluck
[email protected]
605.331.5890
SOURCE Orthopedic Institute
TEA, S.D., Aug. 24, 2026 /PRNewswire/ -- James T. Brunz, MD, an interventional spine and pain physician with Orthopedic Institute (OI), has been recognized by Abbott Neuromodulation as a Spinal Cord Stimulation (SCS) Center of Excellence physician based on his experience, clinical insights, and long-standing work with stimulation-based therapies for chronic pain.
According to Abbott Neuromodulation, Dr. Brunz is a strong proponent of spinal cord stimulation therapy and has served as a consultant on product design. He has performed more than 2,000 SCS implants throughout his career. Abbott has indicated that his experience places him among the top 5% of SCS implanters in the Upper Midwest and top 10% across the broader Midwest.
Spinal cord stimulation is an advanced neuromodulation therapy for select patients with chronic pain who have not achieved adequate relief through more conservative treatments. Dr. Brunz's neuromodulation practice includes spinal cord stimulation and dorsal root ganglion (DRG) stimulation, with an emphasis on careful patient selection and appropriate therapy matching.
"Dr. Brunz has demonstrated significant experience and clinical insight in spinal cord stimulation and neuromodulation therapy," said Todd Woodson, Area Vice President, Abbott Neuromodulation. "Based on his experience, procedural history, and contributions as a clinical resource, Abbott Neuromodulation recognizes Dr. Brunz as a Spinal Cord Stimulation Center of Excellence physician."
"I have worked directly with Dr. Brunz in the operating room and have seen firsthand his experience, consistency, and understanding of spinal cord stimulation therapy," said Scott Mattecheck, Territory Manager, Abbott Neuromodulation. "He has been a valuable clinical resource in the region for patients with complex chronic pain."
"Spinal cord stimulation is not appropriate for every patient, but for carefully selected individuals with chronic pain that has not responded to other treatments, it can be an important therapy to consider," said Dr. Brunz. "My focus is identifying the source of a patient's pain and matching the right treatment to the right patient."
A fellowship-trained interventional spine physician with more than 20 years of experience, Dr. Brunz treats complex spine and pain conditions at Orthopedic Institute, collaborating with orthopedic surgeons, rehabilitation specialists, and advanced practice providers.
In addition to his Abbott designation, Dr. Brunz is a listed Intracept Center of Excellence physician for vertebrogenic low back pain. He is the only physician in South Dakota recognized with both the Abbott Neuromodulation Spinal Cord Stimulation Center of Excellence and Intracept Center of Excellence distinctions.
Patients considered for SCS may include those with chronic pain that has not improved adequately with conservative care or previous treatment. Candidates typically complete a temporary stimulation trial before permanent implantation to determine whether the therapy provides meaningful relief.
About Dr. James T. Brunz
James T. Brunz, MD, is a fellowship-trained interventional spine and pain physician at Orthopedic Institute specializing in complex spine and pain conditions. His clinical focus includes vertebrogenic low back pain, basivertebral nerve ablation, spinal cord stimulation, dorsal root ganglion stimulation, and advanced interventional pain care. He has served as a regional clinical resource and key opinion leader in neuromodulation since being recognized by St. Jude Medical/Abbott in 2013.
About Orthopedic Institute
Founded in 1972, Orthopedic Institute (OI) is an independent physician group specializing in orthopedics, sports medicine, and interventional spine and pain care. With 21 physicians and more than 225 employees, OI serves patients across South Dakota, Minnesota, and Iowa from its main clinic in Tea, South Dakota, and regional locations. www.orthopedicinstitutesf.com
Media Contact:
Helen Kluck
[email protected]
605.331.5890
SOURCE Orthopedic Institute
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。